TNA
True North Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Sell |
17,194
-6,499
| -27% | -$1.21M | 0.61% | 33 |
|
|
2025
Q1 | $4.96M | Sell |
23,693
-2,362
| -9% | -$495K | 0.88% | 20 |
|
|
2024
Q4 | $4.63M | Buy |
26,055
+20,553
| +374% | +$3.65M | 1.09% | 13 |
|
|
2024
Q3 | $1.09M | Sell |
5,502
-20
| -0.4% | -$3.95K | 0.28% | 61 |
|
|
2024
Q2 | $947K | Sell |
5,522
-1,107
| -17% | -$190K | 0.25% | 65 |
|
|
2024
Q1 | $1.21M | Buy |
6,629
+118
| +2% | +$21.5K | 0.33% | 54 |
|
|
2023
Q4 | $1.01M | Sell |
6,511
-169
| -3% | -$26.2K | 0.26% | 57 |
|
|
2023
Q3 | $996K | Sell |
6,680
-161
| -2% | -$24K | 0.31% | 60 |
|
|
2023
Q2 | $922K | Buy |
6,841
+2,109
| +45% | +$284K | 0.26% | 76 |
|
|
2023
Q1 | $754K | Buy |
4,732
+426
| +10% | +$67.9K | 0.22% | 102 |
|
|
2022
Q4 | $696K | Buy |
4,306
+676
| +19% | +$109K | 0.24% | 92 |
|
|
2022
Q3 | $487K | Sell |
3,630
-342
| -9% | -$45.9K | 0.16% | 117 |
|
|
2022
Q2 | $608K | Buy |
+3,972
| New | +$608K | 0.19% | 106 |
|
|
2022
Q1 | – | Sell |
-6,445
| Closed | -$872K | – | 198 |
|
|
2021
Q4 | $872K | Sell |
6,445
-3,977
| -38% | -$538K | 0.15% | 117 |
|
|
2021
Q3 | $1.12M | Buy |
10,422
+2,786
| +36% | +$300K | 0.22% | 98 |
|
|
2021
Q2 | $860K | Buy |
7,636
+431
| +6% | +$48.5K | 0.18% | 104 |
|
|
2021
Q1 | $779K | Sell |
7,205
-1,248
| -15% | -$135K | 0.18% | 100 |
|
|
2020
Q4 | $905K | Buy |
8,453
+991
| +13% | +$106K | 0.23% | 83 |
|
|
2020
Q3 | $653K | Buy |
7,462
+158
| +2% | +$13.8K | 0.19% | 93 |
|
|
2020
Q2 | $717K | Buy |
7,304
+4,205
| +136% | +$413K | 0.17% | 97 |
|
|
2020
Q1 | $236K | Buy |
3,099
+18
| +0.6% | +$1.37K | 0.08% | 108 |
|
|
2019
Q4 | $272K | Buy |
+3,081
| New | +$272K | 0.08% | 88 |
|